Product Code: ETC9619468 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Taiwan External Ventricular Drain (EVD) market is experiencing steady growth due to the rising prevalence of neurological disorders, traumatic brain injuries, and other conditions requiring cerebrospinal fluid drainage. Key market players in Taiwan include healthcare companies offering a range of EVD devices, such as Codman Neuro, Integra LifeSciences, and Medtronic. The market is driven by technological advancements in EVD devices, increasing healthcare infrastructure, and a growing elderly population prone to neurological conditions. Additionally, the rising awareness about the benefits of early diagnosis and treatment of neurological disorders is boosting the demand for EVD procedures in Taiwan. The market is characterized by stringent regulatory standards, competitive pricing strategies, and the emphasis on product innovation to cater to the evolving healthcare needs of patients.
The Taiwan External Ventricular Drain (EVD) market is experiencing growth due to the increasing prevalence of neurological disorders and traumatic brain injuries in the region. Key trends include the rising demand for minimally invasive surgical procedures, technological advancements in EVD devices for improved patient outcomes, and the expanding geriatric population requiring neurosurgical interventions. Opportunities in the market lie in the development of innovative EVD technologies, strategic partnerships between healthcare providers and medical device manufacturers, and the adoption of advanced healthcare infrastructure in Taiwan. Additionally, the growing awareness about the importance of early diagnosis and treatment of neurological conditions is driving the demand for EVD devices in the country, presenting a promising outlook for market expansion and revenue generation.
In the Taiwan External Ventricular Drain (EVD) market, key challenges include intense competition among manufacturers leading to pricing pressures, regulatory complexities, and a shortage of skilled neurosurgeons proficient in EVD procedures. The market is also impacted by the high cost of EVD devices and associated accessories, which may limit adoption rates, particularly in smaller healthcare facilities. Furthermore, the reliance on imported EVD technology exposes the market to fluctuations in exchange rates and trade policies, affecting overall market growth and stability. To succeed in the Taiwan EVD market, companies must navigate these challenges by offering innovative yet cost-effective solutions, investing in local training programs for healthcare professionals, and establishing strong partnerships with local distributors to ensure market penetration and sustainability.
The Taiwan External Ventricular Drain (EVD) Market is primarily driven by factors such as increasing prevalence of neurological disorders, rising geriatric population prone to conditions requiring neurosurgical interventions, and advancements in healthcare infrastructure. The growing demand for minimally invasive procedures, coupled with the rising awareness about the benefits of EVD in treating conditions like hydrocephalus and traumatic brain injuries, is also contributing to market growth. Additionally, the adoption of technological innovations in EVD devices, such as programmable valves and integrated monitoring systems, is further fueling market expansion. Moreover, the government initiatives aimed at improving healthcare facilities and access to advanced medical treatments in Taiwan are expected to drive the growth of the EVD market in the region.
The Taiwanese government has implemented various regulations and policies to govern the External Ventricular Drain (EVD) market. The Taiwan Food and Drug Administration (TFDA) is responsible for overseeing the registration and approval process for medical devices, including EVDs, to ensure their safety and efficacy. Manufacturers and distributors of EVDs must comply with Good Manufacturing Practices (GMP) and quality control standards set by the TFDA. Additionally, there are regulations in place to monitor pricing and reimbursements for medical devices, which can impact market access and pricing strategies for EVDs in Taiwan. Overall, the government policies aim to safeguard public health, promote innovation in the medical device industry, and ensure the availability of high-quality EVDs to healthcare providers and patients in Taiwan.
The Taiwan External Ventricular Drain (EVD) market is expected to witness steady growth in the coming years due to the increasing prevalence of neurological disorders and traumatic brain injuries in the region. The demand for EVDs is also likely to be driven by factors such as advancements in healthcare infrastructure, rising awareness about the importance of early diagnosis and treatment of neurological conditions, and the growing elderly population. Additionally, technological advancements in EVD devices, such as the development of minimally invasive and programmable systems, are expected to further fuel market growth. However, challenges such as stringent regulatory requirements and the high cost of EVD devices may hinder market expansion to some extent. Overall, the Taiwan EVD market is anticipated to show promising growth opportunities in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan External Ventricular Drain Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan External Ventricular Drain Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan External Ventricular Drain Market - Industry Life Cycle |
3.4 Taiwan External Ventricular Drain Market - Porter's Five Forces |
3.5 Taiwan External Ventricular Drain Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.6 Taiwan External Ventricular Drain Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Taiwan External Ventricular Drain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders and traumatic brain injuries in Taiwan |
4.2.2 Technological advancements in external ventricular drain systems leading to improved patient outcomes |
4.2.3 Growing awareness among healthcare professionals about the benefits of using external ventricular drains |
4.3 Market Restraints |
4.3.1 High cost associated with external ventricular drain procedures and devices |
4.3.2 Limited availability of skilled neurosurgeons and healthcare facilities in certain regions of Taiwan |
5 Taiwan External Ventricular Drain Market Trends |
6 Taiwan External Ventricular Drain Market, By Types |
6.1 Taiwan External Ventricular Drain Market, By Patient Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan External Ventricular Drain Market Revenues & Volume, By Patient Type, 2021- 2031F |
6.1.3 Taiwan External Ventricular Drain Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.1.4 Taiwan External Ventricular Drain Market Revenues & Volume, By Adult, 2021- 2031F |
6.2 Taiwan External Ventricular Drain Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan External Ventricular Drain Market Revenues & Volume, By Traumatic Brain Injury, 2021- 2031F |
6.2.3 Taiwan External Ventricular Drain Market Revenues & Volume, By Subarachnoid Hemorrhage, 2021- 2031F |
6.2.4 Taiwan External Ventricular Drain Market Revenues & Volume, By Intracerebral Hemorrhage, 2021- 2031F |
6.2.5 Taiwan External Ventricular Drain Market Revenues & Volume, By Other, 2021- 2031F |
7 Taiwan External Ventricular Drain Market Import-Export Trade Statistics |
7.1 Taiwan External Ventricular Drain Market Export to Major Countries |
7.2 Taiwan External Ventricular Drain Market Imports from Major Countries |
8 Taiwan External Ventricular Drain Market Key Performance Indicators |
8.1 Average length of stay in hospitals for patients undergoing external ventricular drain procedures |
8.2 Number of research studies and clinical trials focusing on external ventricular drains in Taiwan |
8.3 Adoption rate of new external ventricular drain technologies in hospitals and healthcare facilities |
9 Taiwan External Ventricular Drain Market - Opportunity Assessment |
9.1 Taiwan External Ventricular Drain Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.2 Taiwan External Ventricular Drain Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Taiwan External Ventricular Drain Market - Competitive Landscape |
10.1 Taiwan External Ventricular Drain Market Revenue Share, By Companies, 2024 |
10.2 Taiwan External Ventricular Drain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |